Schedule 13D ownership disclosure

CASI PHARMACEUTICALS INC

Security class unavailable · CUSIP: 14757U109

Event date: 2016-07-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
3.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-18-002110
Form type
SC 13D
Filer
CASI Pharmaceuticals, Inc (DE)
CIK
CIK 895051
Filed
Jan 12, 2018
Reporting period
Jul 05, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub